Doug Drysdale

Doug Drysdale⁠

A BetterLife Pharma

Executive Chairman at A BetterLife Pharma

About

I'm Executive Chairman of A BetterLife Pharma, and I was Founding CEO of Alvogen.

Experiences

  1. Executive Chairman at A BetterLife PharmaChair a biotech making a non-hallucinogenic LSD drug

    After nine months advising, I became chair. We closed a US$100M round, unusual for a preclinical company.

  2. Founder at KatogenScored 107 drug trials and found only 11 well powered

    I write Katogen Insights, and I own my misses: my semaglutide model had one dial, the business had two.

  3. Chief Executive Officer at Cybin Inc.Took psychedelic depression drugs to Phase 3 in 3 years

    CYB003 earned FDA Breakthrough Therapy status, with about 75% of patients in remission after two doses.

  4. President & Chief Executive Officer and Director at Tedor Pharma, Inc.Grew a controlled-drug manufacturer 65% in year one

    I led the recapitalization of a contract maker of DEA-scheduled pills, and we made the Inc. 5000 list.

  5. Chairman, President & CEO at Pernix TherapeuticsTurned around a Nasdaq pain and CNS drug company

    We hit positive EBITDA in two quarters and launched a direct-to-patient pharmacy. Value rose from $80M to $800M.

  6. Chief Executive Officer at AlvogenBootstrapped a generics startup to $500M in revenue

    My first CEO job. Impatient investors and my mentor Róbert Wessman pushed us hard, and it later sold for about $2B.

  7. Head of M&A at ActavisLed 15 pharma acquisitions before my first CEO job

    As head of M&A I also sat on the executive board, and we raised $3 billion.

  8. BSc (Hons), Microbial & Molecular Biology at University of East AngliaTrained in the lab before running drug companies

    I did a lab sciences course at Anglia Ruskin, then a BSc in microbial and molecular biology at East Anglia.

Follow Doug for more...

LinkedInXWebsite

© 2026 Delphi · Terms · Privacy

Doug Drysdale

Doug Drysdale⁠

A BetterLife Pharma

Executive Chairman at A BetterLife Pharma

About

I'm Executive Chairman of A BetterLife Pharma, and I was Founding CEO of Alvogen.

Experiences

  1. Executive Chairman at A BetterLife PharmaChair a biotech making a non-hallucinogenic LSD drug

    After nine months advising, I became chair. We closed a US$100M round, unusual for a preclinical company.

  2. Founder at KatogenScored 107 drug trials and found only 11 well powered

    I write Katogen Insights, and I own my misses: my semaglutide model had one dial, the business had two.

  3. Chief Executive Officer at Cybin Inc.Took psychedelic depression drugs to Phase 3 in 3 years

    CYB003 earned FDA Breakthrough Therapy status, with about 75% of patients in remission after two doses.

  4. President & Chief Executive Officer and Director at Tedor Pharma, Inc.Grew a controlled-drug manufacturer 65% in year one

    I led the recapitalization of a contract maker of DEA-scheduled pills, and we made the Inc. 5000 list.

  5. Chairman, President & CEO at Pernix TherapeuticsTurned around a Nasdaq pain and CNS drug company

    We hit positive EBITDA in two quarters and launched a direct-to-patient pharmacy. Value rose from $80M to $800M.

  6. Chief Executive Officer at AlvogenBootstrapped a generics startup to $500M in revenue

    My first CEO job. Impatient investors and my mentor Róbert Wessman pushed us hard, and it later sold for about $2B.

  7. Head of M&A at ActavisLed 15 pharma acquisitions before my first CEO job

    As head of M&A I also sat on the executive board, and we raised $3 billion.

  8. BSc (Hons), Microbial & Molecular Biology at University of East AngliaTrained in the lab before running drug companies

    I did a lab sciences course at Anglia Ruskin, then a BSc in microbial and molecular biology at East Anglia.

Follow Doug for more...

LinkedInXWebsite

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.